NSGC Practice Guideline Process

The NSGC Practice Guidelines Committee works with authors to produce Evidence-Based Clinical Practice Guidelines through an established guideline process. The Guideline Development Manual outlines NSGC's criteria and includes an Appendix with all relevant forms, documents, and background for authors and individuals who submit topic proposals. The Committee also has established criteria for Practice Resource documents, which focus on topics that do not have an evidence-base to meet NSGC's Practice Guideline criteria.

NSGC Practice Guidelines & Practice Resources Information

• Practice Guideline Development Manual (revised in 2020)
• Practice Guideline Development Manual Appendices
• The Differences Between a Practice Guideline and Practice Resource
• Practice Guideline Topic Proposal Form
• Practice Resource Topic Proposal Form

NSGC Practice Guidelines Conflict of Interest Documents

• Practice Guidelines COI Disclosure Form

NSGC Practice Guidelines Leadership, 2024

• Ashley Svenson, Chair
• Chenery Lowe, Vice Chair

NSGC Practice Guidelines Member Access

To access the full articles, please visit the Journal of Genetic Counseling. By accessing the Journal through the NSGC website portal, you can search for practice guidelines you would like to view.

NSGC Practice Guidelines, by Topic

• Epilepsy (October 2022)
  • This guideline was endorsed by the American Epilepsy Society on September 16, 2022.
• Expanded Carrier Screening (February 2023)
• Telehealth Genetic Counseling (August 2022)

NSGC Practice Resources, by Topic

• Alzheimer Disease (June 2011 - reclassified 2018)
• Cancer Predisposition Evaluation (November 2014) (Reclassified as a Practice Resource - 2019)
  • Addendum (July 2019)
• Clinical Documentation (August 2021)
• Congenital Heart Disease (September 2021)
• Consanguinity (December 2002)
  • Addendum (July 2021)
• Cystic Fibrosis (September 2013 - reclassified 2018)
• Diabetes Mellitus (August 2023)
• Down Syndrome (May 2011 - reclassified 2016)
• Elective Genomic Testing (January 2023)
• Fabry Disease (NSGC focused revision published in September 2020)
• Fragile X Syndrome (September 2012 - reclassified 2017)
• Hereditary Breast and Ovarian Cancer (January 2021)
• Lynch Syndrome (January 2022)
• Neurofibromatosis Type 1 (June 2020)
• Pedigree Nomenclature (September 2008 - focused revision September 2022)
• Polygenic Risk Scores (January 2023)
• Prenatal Screening (September 2012 - reclassified 2017)

NSGC Systematic Evidence Reviews

• Telegenetics (October 2021)
• Epilepsy (December 2021)
• Expanded Carrier Screening (February 2022)
• Hypertrophic Cardiomyopathy
  • Journal of Genetic Counseling (July 2022)
  • Open Heart (April 2022)

Practice Guidelines and Practice Resources in Development

Please click here to view a listing of Practice Guidelines and Practice Resources in development and their author groups.

Retired NSGC Practice Guidelines, by Topic

• Cancer Risk (December 2011)
• Recurrent Miscarriage (June 2005)